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Retinal vein occlusion 
VEGF 
A B S T R A C T   
Retinal vein occlusion (RVO) is a vascular disease that represents characteristic retinal hemorrhage and dilated 
retinal veins. Despite its clinical importance, its pathogenesis remains largely unknown because of limited op-
portunities to acquire human retinal samples. Therefore, an animal model that reproduces the clinical features of 
RVO patients is required for further investigation. In this study, we established a pigmented murine RVO model 
that reproduced characteristic fundus appearances similar to human RVO findings. Retinal edema in this model 
was observed in both optical coherence tomography and histological analysis, which is a clinically important 
outcome. With quantitative real-time PCR analysis on retinal samples, we revealed that the mRNA level of 
vascular endothelial growth factor (VEGF) increased in the retina induced RVO. Moreover, this retinal edema 
was reduced by intravitreal injection of anti-VEGF antibody. These results were consistent with human clinical 
knowledge and suggested that this model could be a useful tool for research into new therapeutic approaches.   
1. Introduction 
Retinal vein occlusion (RVO) is a sight-threatening retinal vascular 
disease that causes characteristic retinal hemorrhage and macular 
edema and results in severe vision loss (Thorell and Goldhardt, 2016). 
RVO is an important matter in the clinical field because it is not a rare 
disease in middle- and senior-aged patients. Indeed, RVO is the second 
most common retinal vascular disease (Branch Vein Occlusion Study, 
1984; Rogers et al., 2010). Moreover, RVO-related macular edema often 
developed into a refractory disease until the recent advance of 
anti-vascular endothelial growth factor (VEGF) therapy, and RVO is the 
fifth most frequent cause of unilateral blindness (Cugati et al., 2006; 
Mitchell et al., 1996). Therefore, clinical management of RVO has been 
an important problem for ophthalmologists. 
Despite its clinical importance and attractiveness as a research topic, 
there remain many unknowns about the pathomechanism of RVO (Kida, 
2017). This is partly due to the paucity of opportunities to obtain human 
retinal tissue, and there have been only a few studies using human 
posterior ocular segment samples of RVO patients (Ehlken et al., 2015; 
Noma et al., 2009). In the current situation in which surgical indication 
for RVO is reduced due to anti-VEGF therapy, the validity of an animal 
RVO model that can directly use a retinal tissue sample becomes more 
and more important. 
We have reported a murine RVO model using an albino non- 
pigmented strain (ddY) (Fuma et al., 2017). This model can evaluate 
retinal edema by histological retinal thickness analysis regardless of the 
position of laser irradiation site. Hence, a drug efficacy test assessing 
retinal edema, which is a clinically important outcome, can be per-
formed in this model (Nishinaka et al., 2017). Gene expression analysis 
using a retinal sample was also performed to confirm whether 
RVO-related genes (vascular endothelial growth factor A: VEGF-A, 
aquaporin 4: AQP-4) and inflammatory genes (interleukin-6: IL-6, 
intercellular adhesion molecule 1: ICAM-1, monocyte chemoattractant 
protein 1: MCP-1, platelet derived growth factor A: PDGF-A) were 
altered. The ability to perform such analyses directly using a retinal 
sample is the advantage of an animal RVO model. The only disadvantage 
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of this model is that the mouse strain is albino, which has a 
non-pigmented retina not similar to the human pigmented retina. 
In the laser-induced RVO model using the principle of photo-
thrombosis, albino mice have the advantage of reducing the retinal 
damage caused by scattered laser due to the non-pigmented retina which 
absorb little light energy, resulting in less unintentional inflammation 
effects on the retinal tissue (Ebneter et al., 2015). However, there are 
some disadvantages of albino retina, such as reduction of antioxidant 
response due to deficiency of melanin (Chowers et al., 2017; Wang et al., 
2006) and incomplete retinal pigment epithelial tight junction which is 
the component of outer blood-retinal barrier (BRB) (Iwai-Takekoshi 
et al., 2016). Since oxidative stress is elevated in RVO (Chen et al., 2019) 
and BRB plays an important role in the formation of retinal edema, roles 
of retinal pigments in RVO pathogenesis are not negligible. Moreover, an 
RVO model using a pigmented mouse strain is useful tool because most 
transgenic mice have a background of a pigmented strain, such as 
C57BL/6J. 
There have been some previous reports of a murine RVO model using 
pigmented mouse stain (Allingham et al., 2018; Avrutsky et al., 2020; 
Dominguez et al., 2015; Hirabayashi et al., 2019; Martin et al., 2018; 
Uddin et al., 2017; Zhang et al., 2007). These models have many ad-
vantages such as ease of handling and cost effectiveness, and they can 
use many mutant and genetically engineered strains. However, the 
characteristic retinal hemorrhage, called a feather- or flame-shaped 
hemorrhage, is not observed in a half of these models, and even the 
models that have presented hemorrhage, there are some disadvantages 
in terms of effect area and success rate of occlusion (Hirabayashi et al., 
2019). Considering that the disease concept of RVO has been established 
based on its fundus appearance (Behrman, 1968; Williamson, 1997), it 
would be more desirable that characteristic fundus findings in human 
RVO patients are reproduced in an animal model, such as superficial 
hemorrhage along the course of the nerve fiber layer, dilated and 
tortuous retinal veins, and a normal appearance of non-occluded retina. 
Here, we show a novel pigmented murine RVO model using the 
C57BL/6J strain that represents many fundus findings similar to human 
RVO and can be used to estimate retinal edema quantitatively. 
2. Materials and methods 
2.1. Animals 
All investigations were performed in accordance with the Associa-
tion for Research in Vision and Ophthalmology (ARVO) Statement for 
the Use of Animals in Ophthalmic and Vision Research, and the exper-
iments were approved and monitored by the Institutional Animal Care 
and Use Committee of Gifu Pharmaceutical University. Eight-week-old 
male C57BL/6J mice were purchased from Japan SLC (Hamamatsu, 
Japan) and kept in animal facilities maintained at 23 ± 3 ◦C under a 12-h 
light and 12-h dark schedule. 
2.2. RVO model 
The mice were anesthetized with a mixture of ketamine (120 mg/kg; 
Daiichi-Sankyo, Tokyo, Japan) and xylazine (6 mg/kg; Bayer, Health 
Care Osaka, Japan). Pupils were dilated with 1% tropicamide and 2.5% 
phenylephrine (Santen Pharmaceuticals Co., Osaka, Japan), and puri-
fied sodium hyaluronate (Santen Pharmaceuticals Co.) was applied 
topically to the cornea to prevent desiccation. A dose of rose bengal 
(0.15 ml, 8 mg/ml; Wako, Osaka, Japan) was injected into a tail vein. 
After 20 min from the injection, about 20–30 laser shots per vein (three 
veins/animal) were applied to a branch vein (3 disc diameters from the 
optic nerve centers) of either eye of each animal after confirming that 
the anesthesia was adequate. The image-guided laser system (532 nm) 
attached to a Micron IV Retinal Imaging Microscope (Phoenix Research 
Laboratories, Pleasanton, CA, USA) was used at 130 mW power, 300 ms 
duration, and 50 μm size. A sham laser was performed between the large 
vessels, avoiding vascular occlusion at the same irradiation condition 
but without administration of rose bengal. Photosensitive substance 
(rose bengal) was not administrated in the sham group in order to 
evaluate the effect of laser irradiation itself as possible as without the 
effect of vascular occlusion. In addition, the group induced vein occlu-
sion without interval after rose bengal administration was set (Supple-
mentary Fig. 1). 
2.3. Fundus photography 
The ocular fundus was observed using a Micron IV Retinal Imaging 
Microscope (Phoenix Research Laboratories). Five microliters of 
ophthalmic solution containing 0.5% tropicamide and 0.5% phenyl-
ephrine hydrochloride (Santen Pharmaceuticals Co.) were applied top-
ically to dilate the pupil after anesthesia using ketamine and xylazine. A 
few minutes later, purified sodium hyaluronate (Santen Pharmaceuticals 
Co.) was applied topically to prevent desiccation and to keep the surface 
smooth. 
2.4. Optical coherence tomography imaging 
OCT images were taken using a Micron IV fundus camera and an OCT 
Scan Head equipped with a mouse objective lens (Phoenix Research 
Laboratories). The OCT device featured a broadband superluminescent 
diode at 830 nm, customized for retinal imaging of mice. 
2.5. Histological analysis 
To visualize histological changes, we performed H&E staining of 
mouse eye sections at 1 and 3 days after vein occlusion or sham laser 
irradiation. Mice were euthanized by cervical dislocation under deep 
anesthesia, and each eye was enucleated. Eyes used for histological 
analysis were kept immersed for at least 48 h at 4 ◦C in a fixative solution 
containing 4% paraformaldehyde. Six paraffin-embedded sections 
(thickness, 5 μm) were cut in parallel with the maximal circumference 
through the optic disc. Eye sections were then prepared in the standard 
manner and stained with H&E. The damage induced by retinal vein 
occlusion was then evaluated using three H&E-stained sections from 
each eye for morphometric analysis. Light-microscope images were 
photographed, and the thickness of the total retina, ganglion cell layer 
(GCL), inner nuclear layer (INL), and outer nuclear layer (ONL) were 
measured on the photographs at 240 μm intervals from the optic disc. 
2.6. Drug administration 
Mouse anti-VEGF antibody (200 μg/mL; R&D Systems, Minneapolis, 
MN, USA) was used to confirm whether VEGF was involved in the 
development of edema in our experimental RVO model. Immediately 
after laser photothrombosis, mice received an intravitreal injection of 
anti-VEGF antibody in their treated eyes, and histological evaluation 
was performed at 3 days after vein occlusion. Sterile 34-gauge needles 
(Terumo, Tokyo, Japan) were attached to fine-bore tubes (Natsume 
Seisakusho, Tokyo, Japan) and filled with anti-VEGF antibody. A 
microsyringe was connected to the opposite side of the tube. Under 
microscopic guidance, the limbus of the cornea was pierced toward the 
posterior segment with a needle, and then 2 μL of anti-VEGF antibody 
was administered into the vitreous cavity. After intravitreal injections, 
the sclera was disinfected with 0.5% levofloxacin (Santen Pharmaceu-
ticals Co.). Phosphate-buffered saline was used as a vehicle. 
2.7. RNA extraction and real-time PCR 
To examine time-dependent changes in RVO-related genes and in-
flammatory genes expression after laser irradiation, retinas induced 
RVO or irradiated sham laser were obtained at 0.5, 1, and 3 days after 
laser irradiation. Mice were euthanized by cervical-spine dislocation, 
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and the eyeballs quickly removed. Retinas were carefully separated from 
the eyeballs and rapidly frozen in liquid nitrogen. RNA was isolated from 
retinas with the aid of a High Pure RNA Isolation kit (Roche Diagnostics, 
Tokyo, Japan). RNA concentrations were determined spectrophoto-
metrically at 260 nm. First-strand cDNA was synthesized in 10 μL re-
action volumes using a PrimeScript RT reagent kit (Perfect Real Time; 
Takara Bio, Shiga, Japan). Gene expression was quantified by means of 
real-time PCR, performed using SYBR Premix Ex Taq (Takara Bio) and a 
TP 8000 Thermal Cycler Dice Real Time system (Takara Bio). The PCR 
primer sequences of VEGF-A, IL-6, MCP-1, ICAM-1, PDGF-A and AQP-4 
were as follows: 
VEGF-A, 
5′-ACATTGGCTCACTTCCAGAAACAC-3′ (forward) and 
5′-GGTTGGAACCGGCATCTTTATC-3′ (reverse) 
IL-6, 
5′-TCTGCAAGAGACTTCCATCCAGT -3′ (forward) and 
5′-TCTGCAACTGCATCATCGTTGT-3′ (reverse) 
MCP-1, 
5′-CTGAAGCCAGCTCTCTCTTCCT-3′ (forward) and 
5′-CAGGCCCAGAAGCATGACA-3′ (reverse) 
ICAM-1, 
5′-CGCTGTGCTTTGAGAACTGTG-3′ (forward) and 
5′-ATACACGGTGATGGTAGCGGA-3′ (reverse) 
AQP-4, 
5′-GAGTATGTCTTCTGTCCTG-3′ (forward) and 
5′-ACGGTCAATGTCAATCAC-3′ (reverse) 
PDGF-A, 
5′-GTCCAGGTGAGGTTAGAGG-3′ (forward) and 
Fig. 1. Fundus findings in the murine RVO model. 
(A) Diagram showing the method of RVO induc-
tion. (B) Fundus images of this model at the pos-
terior pole (left) and peripheral retina (right). 
Superficial retinal hemorrhages were observed in 
the occluded area (arrow). The characteristic shape 
of these hemorrhages typical of RVO is a so-called 
feather- or flame-shaped hemorrhage. Retinal ar-
teries were not occluded, and non-treated retina 
showed a normal appearance (dashed circle). A 
well-ordered reflex from the retinal nerve fiber 
layer may suggest the maintained structure of non- 
treated retina. The retinal vein was dilated and 
tortuous (arrowhead) upstream of the occluded 
site. (C) Typical color images of the fundus and 
OCT images of the RVO murine eye at day 1. The 
OCT images spanning the occluded area and the 
non-treated area showed a retinal edema at the 
occluded retina. The non-treated retina was rela-
tively maintained. The asterisk indicates the retinal 
edema. Scale bar = 50 μm. (D) Time-dependent 
change of fundus appearance in this RVO model. 
At day 3, the superficial hemorrhage seems to 
become thinner and slightly broader. Arrowheads 
indicate the increase of retinal transparency and 
vascular bending.   
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5′-CACGGAGGAGAACAAAGAC-3′ (reverse) 
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) 
5′-GGGATGGTCCTTGCATCAGAA-3′ (forward) and 
5′-ACTGGTAGCCACTGGTCTGGTTG-3′ (reverse) 
2.8. Statistics and image analysis 
Statistical analyses were performed using EZR software (v1.40), 
which is a modified version of R commander (Kanda, 2013). Data are 
presented as means ± SE. Statistical comparisons were conducted using 
one-way ANOVA followed by Tukey HSD test and Kruskal–Wallis test 
followed by Steel’s multiple comparison test and two-way ANOVA. 
P-values < 0.05 were considered statistically significant. Manual image 
analysis using ImageJ software (National Institutes of Health) was per-
formed to measure the thickness of the retina. Fundus images were 
adjusted for brightness and contrast and color tone using Photoshop CC 
2020 (Adobe, San Jose, CA, USA). 
3. Results 
3.1. Fundus findings 
To induce RVO in pigmented mice, laser irradiation (130 mW, 300 
ms, 50 μm, 20–30 shots per vein) was performed 20 min after intrave-
nous injection of 0.15 ml rose bengal (8 mg/ml) in 8 week-old male 
C57BL/6J mice (Fig. 1A). 
From 12 h after vein occlusion, superficial retinal hemorrhages were 
observed (Fig. 1B). These hemorrhages were uniquely shaped along the 
course of the retinal nerve fiber layer and were similar to human RVO 
findings called feather- or flame-shaped hemorrhages. Dilated and 
tortuous veins were observed upstream of the occlusion site. Retinal 
arteries were not occluded, and non-treated retina showed a normal 
color appearance. Retinal edema was observed by OCT images in the 
occluded area (Fig. 1C). These findings suggest that the novel RVO 
model reproduced the fundus appearance of human patients. At 3 days 
after occlusion, the increase of retinal transparency and vascular 
bending suggested a retinal exudative increase (Fig. 1D). We performed 
fundus image check on consecutive case of RVO-induced mouse in-
dividuals by the single operator to confirm the reproducibility of the 
fundus findings shown in Fig. 1 (Supplementary Fig. 2). 
Fig. 2. Histological evaluation showed inner nu-
clear layer edema. 
(A) Representative images of H&E stained retina of 
C57BL/6J mice (8 weeks, male) without (Normal) 
or with RVO treatment. GCL edema was observed 
at day 1, and INL was thicker at day 3 than at day 
1. (B) Plots illustrate quantitative thickness data of 
total retina and each retinal layer: GCL, INL, and 
ONL. Data are expressed as means ± S.E.M. (n = 7). 
*: Normal vs. RVO Day 1. †: Normal vs. RVO Day 3. 
‡: RVO Day 1 vs. RVO Day 3. P < 0.05 (one-way 
ANOVA with post-hoc Tukey HSD test). GCL: gan-
glion cell layer. INL: inner nuclear layer. ONL: 
outer nuclear layer. Scale bar = 50 μm.   
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3.2. Histological evaluation 
In tissue sections of RVO, an increase of retinal thickness indicating 
retinal edema occurred at 1 and 3 days after vein occlusion (Fig. 2A). In 
the quantitative assessment of each retinal layer thickness, INL thickness 
increased significantly at 3 days after occlusion (Fig. 2B). GCL thickness 
also increased but largely varied with the measurement site (Fig. 2B). 
ONL thickness barely changed at any time point, and total retina 
thickness increased significantly at 3 days (Fig. 2B). 
In tissue sections of sham laser, retinal layer structures were main-
tained at any time point (Fig. 3B). In the quantitative assessment of each 
retinal layer thickness, each retinal layer did not increase apparently 
(Fig. 3C). Likewise, there were no hemorrhage and no findings that 
suggest retinal edema in fundus images (Fig. 3A). 
3.3. Efficacy test of anti-VEGF antibody administration 
Intravitreal injection of anti-VEGF is the most effective treatment for 
RVO-related macular edema and has become a standard approach for 
RVO management. To assess the effectiveness of anti-VEGF antibody in 
this model, we performed anti-VEGF antibody injection immediately 
after RVO induction. In tissue sections, anti-VEGF antibody reduced the 
structural change of retina after vein occlusion compared to vehicle 
(Fig. 4B). In the quantitative assessment, INL thickness in the anti-VEGF 
group was significantly decreased compared to that of the vehicle group 
(Fig. 4C). Apparent changes of fundus findings were not observed with 
Fig. 3. Sham laser did not cause retinal edema. 
Sham laser was performed in eight-week-old male 
C57BL/6J mice between the large vessels, avoiding 
vascular occlusion. (A) Time-dependent change of 
fundus appearance in sham laser group from Day 
0 to Day 3. As time passes, the laser scars gradually 
become covered with pigment. There were no 
hemorrhage and no findings that suggest retinal 
edema. (B) Representative images of H&E stained 
retinas. Layer structure of retina was maintained in 
sham laser group. (C) Plots illustrate quantitative 
thickness data of total retina and each retinal layer: 
GCL, INL, and ONL. Retinal thickness did not 
apparently increase at any time point in all layers. 
Data are expressed as means ± S.E.M. (n = 7). *: 
Normal vs. Sham 1 day. †: Normal vs. Sham 3 day. 
‡: Sham 1 day vs. Sham 3 day. P < 0.05 (one-way 
ANOVA with post hoc Tukey HSD test). GCL: gan-
glion cell layer. INL: inner nuclear layer. ONL: 
outer nuclear layer. Scale bar = 50 μm.   
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anti-VEGF injection. 
3.4. mRNA expression analysis 
The expression level of VEGF-A increased significantly at 12 h after 
vein occlusion but did not increase in the sham laser group (Fig. 5). This 
result was consistent with the histological evaluation considering that 
VEGF is strongly associated with retinal edema. AQP-4 expression 
decreased significantly at 12 h and 1 day in the RVO group and less 
decreased in the sham group. PDGF-A was not significantly changed in 
either the RVO or sham group. The expression of IL-6, MCP-1, and ICAM- 
1 increased significantly in both the RVO and sham groups. These genes 
are often treated as inflammatory factors (Matsushima et al., 2019; 
Yoshimura et al., 2009). It is notable that there was an increase of these 
factors in the sham group compared to that in the RVO group. This in-
dicates that laser irradiation itself induced a non-negligible 
Fig. 4. Intravitreal injection of anti-VEGF antibody 
ameliorated the INL edema. 
(A) The diagram shows the schedule of RVO in-
duction and anti-VEGF antibody treatment. Intra-
vitreal injection of anti-VEGF antibody was 
performed immediately after RVO induction. His-
tological evaluation was conducted on day 3 (B, C). 
(B) Representative images of H&E stained retinas. 
The layered structure of the retina was relatively 
maintained in the anti-VEGF group compared with 
the vehicle group. The INL layer was thinner in the 
anti-VEGF group than the vehicle group. (C) Plots 
illustrate quantitative thickness data of INL. INL 
thickness was significantly decreased by anti-VEGF 
antibody. Data are expressed as means ± S.E.M. (n 
= 5–7). *: Normal vs. Vehicle. †: Vehicle vs. anti- 
VEGF. P < 0.05 (one-way ANOVA with post-hoc 
Tukey HSD test). GCL: ganglion cell layer. INL: 
inner nuclear layer. ONL: outer nuclear layer. Scale 
bar = 50 μm.   
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inflammatory effect in the pigmented mice model. 
4. Discussion 
We have reported a murine RVO model using the ddY strain, which is 
albino and has a non-pigmented retina (Fuma et al., 2017; Nishinaka 
et al., 2017). Despite the usefulness of this ddY model, a pigmented 
murine strain would be more suitable in that it has a pigmented retina 
similar to those in humans. There have been some previous reports on a 
murine RVO model using a pigmented murine strain. These models are 
divided into two types: models that occlude a single retinal vein to 
imitate branch vein occlusion (Allingham et al., 2018; Dominguez et al., 
2015; Uddin et al., 2017; Zhang et al., 2007) and models that occlude 
multiple veins to affect the entire retina(Avrutsky et al., 2020; Hir-
abayashi et al., 2019; Martin et al., 2018). These two types have both 
advantages and disadvantages. Singe vein occlusion can minimize the 
retinal damage due to laser irradiation, but it is difficult to evaluate the 
effect of occlusion reproducibly because its effect is localized (Fig. 6A). 
In contrast, multiple vein occlusion affects a broader area of the retina, 
so it can perform quantitative evaluation using the entire retina. How-
ever, it requires more laser irradiation than single vein occlusion and 
often causes severe retinal damage. In the present experiments, the in-
crease of laser irradiation energy caused broad retinal whitening and 
constriction of retinal arteries (Fig. 6C). These findings suggest extensive 
prolapse of the capillary network and retinal artery occlusion. In 
summary, although multiple vein occlusion is preferable for quantitative 
evaluation using the entire retina, the fundus image oftentimes seem not 
to represent the typical appearance of human RVO. As described by 
Kazutaka and colleagues (Hirabayashi et al., 2019), the lack of retinal 
hemorrhage in these models would be a considerable disadvantage 
because typical hemorrhage is the most characteristic phenotype of 
RVO. To avoid this problem, we modified the condition of laser irradi-
ation and obtained the typical fundus findings of RVO while conven-
tional irradiation often cause retinal artery occlusion (Fig. 6C). 
The present RVO model showed fundus findings similar to human 
RVO, such as superficial hemorrhage along the course of the nerve fiber 
layer and dilated and tortuous retinal veins in the upper area of the 
occlusion site (Fig. 1B). These findings indicate that laser irradiation in 
our model was minimally invasive to capillary vessels. Considering the 
link between fundus findings and pathology, it may be possible that the 
model more realistically reproduces human RVO pathology than pre-
vious models. The other advantage of the model is that the effectiveness 
of anti-VEGF antibody for retinal edema was confirmed. Retinal edema, 
which is the main pathological event of human RVO, was observed in 
this model (Fig. 2) and was ameliorated by intravitreal injection of anti- 
VEGF antibody (Fig. 4). These results were consistent with human 
clinical knowledge. To the best of our knowledge, this is the first RVO 
model using a pigmented murine strain that showed the reduction of 
retinal edema by anti-VEGF antibody. 
We also evaluated the gene expression changes at the transcriptional 
Fig. 5. mRNA expression analysis of RVO-related 
and inflammatory genes in the murine RVO model. 
The mRNA amount of VEGF-A (A), AQP-4 (B), IL-6 
(C), MCP-1 (D), ICAM-1 (E), and PDGF-A (F) was 
evaluated by real-time PCR analysis at 0.5 (12 h), 
1, and 3 days after RVO induction or sham laser 
irradiation. Data are expressed as means ± S.E.M. 
(n = 8–10). *: RVO vs. sham P < 0.05 (two-way 
ANOVA). †: vs. Normal P < 0.05 (Kruskal–Wallis 
test with post-hoc Steel’s multiple comparison 
test). n.s.: not significant.   
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level by real-time PCR (Fig. 5). The results showed an increase of VEGF- 
A in the RVO group. Considering the improvement of retinal edema by 
anti-VEGF antibody, it could be said that the pathology of retinal edema 
in this RVO model depended on VEGF expression. AQP-4 was signifi-
cantly decreased in the RVO group, and this result was consistent with 
previous reports (Rehak et al., 2009). AQP-4 is considered to play a key 
role in water transport and retinal volume homeostasis (Kida et al., 
2017; Schey et al., 2014). Because there was little change in the sham 
group without retinal edema, AQP-4 may be strongly related to the 
retinal edema caused by vein occlusion in this model. Inflammatory 
factors (IL-6, MCP-1, and ICAM-1) were increased significantly in both 
the RVO and sham groups. Previous reports showed that inflammatory 
factors were increased in RVO (Matsushima et al., 2019; Noma et al., 
2011; Yoshimura et al., 2009), but the fact that the sham laser also 
caused a change in inflammatory expression indicated that laser irra-
diation itself largely affected the retina as well as vein occlusion in this 
model. However, the sham laser did not cause retinal edema in this 
model (Fig. 3), although inflammatory gene expression increased as 
much as that in the RVO group (Fig. 5). Thus, it could be said that 
laser-induced inflammation alone did not cause retinal edema, and the 
effect of vein occlusion would play a key role for retinal edema in this 
model. 
A previous study insisted that a laser-induced murine RVO model 
should be regarded as an inflammation model rather than a vein oc-
clusion model (Martin et al., 2018). However, the results of histological 
and mRNA evaluation indicated that it is not appropriate to regard this 
Fig. 6. Comparison of the fundus images in 
different laser irradiation conditions. 
(A) Color fundus images of previous RVO models. 
Single vein occlusion represents a relatively similar 
appearance to human RVO, but its effect is only 
localized (a). Multiple vein occlusion requires more 
laser irradiation than single vein occlusion, result-
ing in severe retinal damage. Retinal whitening and 
artery constriction are often observed at high 
power laser enough to occlude a vein (b). Low 
power laser to avoid retinal damage resulted in a 
low success rate of occlusion (c). These fundus 
images did not show typical findings as RVO. (B) 
Time-dependent changes of the reaction area of 
photothrombosis after administration of rose ben-
gal. At immediately after, rose bengal reacted in 
wide range of retinal vessels (arrowheads) outside 
the laser irradiation site (asterisk), including retinal 
artery. Over time, the reaction area was limited to 
the near of irradiation site. A red light was laser 
aiming spot. Yellow indicated the reaction light of 
rose bengal. (C) The fundus and OCT images of 
laser-induced vein occlusion with or without in-
terval after rose bengal administration were shown. 
In without interval, constriction of retinal arteries 
and milky whiten retina which lost transparency 
were observed. In OCT, there was high reflection of 
inner layer and obscuration of layer structure 
(arrow), and low signal in outer layer in OCT. 
These findings are usually observed in the retinal 
artery occlusion. In with interval, there were su-
perficial hemorrhage characteristic of RVO and 
normal appearance retina of non-irradiated area. In 
OCT, cystic change was observed in inner nuclear 
layer (arrowhead). Scale bar = 50 μm.   
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model as simply a laser-induced inflammation model, and this model 
seems to reflect the effect of vein occlusion enough to regard it as an 
RVO model. This difference would be due to the timing of laser irradi-
ation in the present method. At 20 min after administration of the 
photosensitive substance, the reaction light of laser irradiation at un-
intended areas of the retina apparently decreased (Fig. 6B). Thus, un-
expected damage of the retina would be reduced. Indeed, the group 
induced vein occlusion without interval after rose bengal administration 
represented fundus and tissue findings suggesting retinal artery occlu-
sion (Supplementary Fig. 1). 
Therefore, the model differs from previously reported RVO models in 
that it can reduce inflammation and would more purely reflect the effect 
of vein occlusion. 
This model has some limitations due to the anatomy of the murine 
retina, such as the lack of a macula. However, considering that retinal 
edema in this model was observed in the inner nuclear layer, which is 
the same layer involved in human RVO-related edema, this may be an 
acceptable difference. Moreover, it is hard to describe this model as 
branch retinal vein occlusion or central retinal vein occlusion. However, 
a method that occludes three branch veins per eye seems to be the right 
balance as the RVO model, because it can affect an extensive area of the 
retina while relatively reducing inflammation. Despite these limitations, 
the present study showed that this pigmented murine RVO model rep-
resented superficial retinal hemorrhage, which is a characteristic finding 
of RVO, and it was possible to quantitatively evaluate retinal edema, 
which is an important outcome in the clinical management of RVO. 
Moreover, this retinal edema was improved by intravitreal injection of 
anti-VEGF antibody, which is consistent with human clinical knowledge, 
and this result can be used as a positive control when investigating new 
therapeutic agents. These results suggest that this is a preferable model 
of RVO for simulating human findings. 
5. Conclusions 
We established a murine RVO model using a pigmented strain that 
showed many findings comparatively similar to RVO patients. This 
model would be useful for clarifying the pathogenesis of RVO and for 
developing novel therapeutic agents. 
Appendix A. Supplementary data 
Supplementary data to this article can be found online at https://doi. 
org/10.1016/j.exer.2021.108441. 
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